Open-label Trial of Leukine in Active Crohn's Disease

NCT00206700 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

378

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn Disease

Interventions

DRUG: Sargramostim (Leukine)

Sponsor

Genzyme, a Sanofi Company